130 related articles for article (PubMed ID: 37086843)
1. Prior MRI-imaging impact of patients submitted to brachytherapy for prostate cancer.
Vieira E Brito D; Fereira A; Pereira J; Pereira-Lourenço M; Godinho R; Pereira B; Peralta P; Conceiçao P; Reis Mario A; Paula Rabaça C
Actas Urol Esp (Engl Ed); 2023 Oct; 47(8):503-508. PubMed ID: 37086843
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment 3T multiparametric MRI staging predicts for biochemical failure in high-risk prostate cancer treated with combination high-dose-rate brachytherapy and external beam radiotherapy.
Hegde JV; Demanes DJ; Veruttipong D; Raince J; Park SJ; Raman SS; Nickols NG; King CR; Kishan AU; Steinberg ML; Kamrava M
Brachytherapy; 2017; 16(6):1106-1112. PubMed ID: 28807747
[TBL] [Abstract][Full Text] [Related]
3. Multiparametric Magnetic Resonance Imaging Is an Independent Predictor of Salvage Radiotherapy Outcomes After Radical Prostatectomy.
Sharma V; Nehra A; Colicchia M; Westerman ME; Kawashima A; Froemming AT; Kwon ED; Mynderse LA; Karnes RJ
Eur Urol; 2018 Jun; 73(6):879-887. PubMed ID: 29195777
[TBL] [Abstract][Full Text] [Related]
4. Multiparametric MRI for the detection of local recurrence of prostate cancer in the setting of biochemical recurrence after low dose rate brachytherapy.
Valle LF; Greer MD; Shih JH; Barrett T; Law YM; Rosenkrantz AB; Shebel H; Muthigi A; Su D; Merino MJ; Wood BJ; Pinto PA; Krauze AV; Kaushal A; Choyke PL; Türkbey B; Citrin DE
Diagn Interv Radiol; 2018; 24(1):46-53. PubMed ID: 29317377
[TBL] [Abstract][Full Text] [Related]
5. Prediction of biochemical recurrence in prostate cancer patients who underwent prostatectomy using routine clinical prostate multiparametric MRI and decipher genomic score.
Jambor I; Falagario U; Ratnani P; Perez IM; Demir K; Merisaari H; Sobotka S; Haines GK; Martini A; Beksac AT; Lewis S; Pahikkala T; Wiklund P; Nair S; Tewari A
J Magn Reson Imaging; 2020 Apr; 51(4):1075-1085. PubMed ID: 31566845
[TBL] [Abstract][Full Text] [Related]
6. Multiparametric magnetic resonance imaging for the assessment of extracapsular invasion and other staging parameters in patients with prostate cancer candidates for radical prostatectomy.
Lista F; Gimbernat H; Cáceres F; Rodríguez-Barbero JM; Castillo E; Angulo JC
Actas Urol Esp; 2014 Jun; 38(5):290-7. PubMed ID: 24387827
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy.
Gandaglia G; Ploussard G; Valerio M; Marra G; Moschini M; Martini A; Roumiguié M; Fossati N; Stabile A; Beauval JB; Malavaud B; Scuderi S; Barletta F; Afferi L; Rakauskas A; Gontero P; Mattei A; Montorsi F; Briganti A
Eur Urol Oncol; 2020 Dec; 3(6):739-747. PubMed ID: 32847747
[TBL] [Abstract][Full Text] [Related]
8. Multiparametric magnetic resonance imaging predicts the presence of prostate cancer in patients with negative prostate biopsy.
Lista F; Castillo E; Gimbernat H; Rodríguez-Barbero JM; Panizo J; Angulo JC
Actas Urol Esp; 2015 Mar; 39(2):85-91. PubMed ID: 25267460
[TBL] [Abstract][Full Text] [Related]
9. Detecting recurrent prostate Cancer using multiparametric MRI, influence of PSA and Gleason grade.
Venkatesan AM; Mudairu-Dawodu E; Duran C; Stafford RJ; Yan Y; Wei W; Kundra V
Cancer Imaging; 2021 Jan; 21(1):3. PubMed ID: 33407861
[TBL] [Abstract][Full Text] [Related]
10. Histological comparison between predictive value of preoperative 3-T multiparametric MRI and
Franklin A; Yaxley WJ; Raveenthiran S; Coughlin G; Gianduzzo T; Kua B; McEwan L; Wong D; Delahunt B; Egevad L; Samaratunga H; Brown N; Parkinson R; Roberts MJ; Yaxley JW
BJU Int; 2021 Jan; 127(1):71-79. PubMed ID: 32524748
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of MR imaging/MR spectroscopy-planned focal partial salvage permanent prostate implant (PPI) for localized recurrence after initial PPI for prostate cancer.
Hsu CC; Hsu H; Pickett B; Crehange G; Hsu IC; Dea R; Weinberg V; Gottschalk AR; Kurhanewicz J; Shinohara K; Roach M
Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):370-7. PubMed ID: 22672747
[TBL] [Abstract][Full Text] [Related]
12. 3-T multiparametric MRI characteristics of prostate cancer patients suspicious for biochemical recurrence after primary focal cryosurgery (hemiablation).
Kongnyuy M; Halpern DM; Liu CC; Kosinski KE; Habibian DJ; Corcoran AT; Katz AE
Int Urol Nephrol; 2017 Nov; 49(11):1947-1954. PubMed ID: 28799121
[TBL] [Abstract][Full Text] [Related]
13. Negative multiparametric magnetic resonance imaging for prostate cancer: further outcome and consequences.
Haack M; Miksch V; Tian Z; Duwe G; Thomas A; Borkowetz A; Stroh K; Thomas C; Haferkamp A; Höfner T; Boehm K
World J Urol; 2022 Dec; 40(12):2947-2954. PubMed ID: 36318314
[TBL] [Abstract][Full Text] [Related]
14. Comparative study between 1.5 and 3 Tesla multiparametric MRI systems using the PIRADS version 2 classification in the diagnosis of prostate cancer.
Cabello MÁR; Rubio SM; Sanz ÁM; Miguelañez JLS; Alba DV; González CA; Sancho AP
Arch Esp Urol; 2022 May; 75(4):330-338. PubMed ID: 35818913
[TBL] [Abstract][Full Text] [Related]
15. The "Is mpMRI Enough" or IMRIE Study: A Multicentre Evaluation of Prebiopsy Multiparametric Magnetic Resonance Imaging Compared with Biopsy.
Stonier T; Simson N; Shah T; Lobo N; Amer T; Lee SM; Bass E; Chau E; Grey A; McCartan N; Acher P; Ahmad I; Arumainayagam N; Brown D; Chapman A; Elf D; Hartington T; Ibrahim I; Leung H; Liyanage S; Lovegrove C; Malthouse T; Mateen B; Mistry K; Morrison I; Nalagatla S; Persad R; Pope A; Sokhi H; Syed H; Tadtayev S; Tharmaratnam M; Qteishat A; Miah S; Emberton M; Moore C; Walton T; Eddy B; Ahmed HU
Eur Urol Focus; 2021 Sep; 7(5):1027-1034. PubMed ID: 33046412
[TBL] [Abstract][Full Text] [Related]
16. Prostate Indeterminate Lesions on Magnetic Resonance Imaging-Biopsy Versus Surveillance: A Literature Review.
Gómez Rivas J; Giganti F; Álvarez-Maestro M; Freire MJ; Kasivisvanathan V; Martinez-Piñeiro L; Emberton M
Eur Urol Focus; 2019 Sep; 5(5):799-806. PubMed ID: 29525382
[TBL] [Abstract][Full Text] [Related]
17. Integration of Prostate Biopsy Results with Pre-Biopsy Multiparametric Magnetic Resonance Imaging Findings Improves Local Staging of Prostate Cancer.
Caglic I; Sushentsev N; Shah N; Warren AY; Lamb BW; Barrett T
Can Assoc Radiol J; 2022 Aug; 73(3):515-523. PubMed ID: 35199583
[TBL] [Abstract][Full Text] [Related]
18. Pattern of relapse and dosimetric analysis of a single dose 19 Gy HDR-brachytherapy phase II trial.
Gomez-Iturriaga A; Buchser D; Mayrata E; San Miguel I; Gonzalez A; Suarez F; Martinez-Indart L; Minguez P; Espinosa J; Perez F; Cacicedo J; Casquero F
Radiother Oncol; 2020 May; 146():16-20. PubMed ID: 32086047
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment Multiparametric Magnetic Resonance Imaging Findings Are More Accurate Independent Predictors of Outcome Than Clinical Variables in Localized Prostate Cancer.
Gomez-Iturriaga A; Casquero F; Pijoan JI; Crook J; Urresola A; Ezquerro A; Villeirs GM; Bossi A; Cacicedo J; Buchser D; Bilbao P
Int J Radiat Oncol Biol Phys; 2018 Aug; 101(5):1172-1178. PubMed ID: 29861199
[TBL] [Abstract][Full Text] [Related]
20. Detection of failure patterns using advanced imaging in patients with biochemical recurrence following low-dose-rate brachytherapy for prostate cancer.
Salerno KE; Turkbey B; Lindenberg L; Mena E; Schott EE; Brennan AK; Roy S; Shankavaram U; Patel K; Cooley-Zgela T; McKinney Y; Wood BJ; Pinto PA; Choyke P; Citrin DE
Brachytherapy; 2022; 21(4):442-450. PubMed ID: 35523680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]